Papers: 10.1371/journal.pone.0088049

https://doi.org/10.1371/journal.pone.0088049

Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cited by: 17
Author(s): Taro Kishi, Yuki Matsuda, Nakao Iwata
Published: almost 13 years ago

Software Mentions 1